Document:

Exhibit 4.1

 

THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER EITHER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR APPLICABLE
STATE SECURITIES LAWS (THE “STATE ACTS”), AND SHALL NOT BE SOLD, ASSIGNED, PLEDGED, HYPOTHECATED, DONATED OR OTHERWISE
TRANSFERRED (WHETHER OR NOT FOR CONSIDERATION) BY THE HOLDER EXCEPT BY REGISTRATION OR PURSUANT TO AN EXEMPTION FROM REGISTRATION
UPON THE ISSUANCE TO THE COMPANY OF A FAVORABLE OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TO
THE EFFECT THAT ANY SUCH TRANSFER SHALL NOT BE IN VIOLATION OF THE 1933 ACT AND THE STATE ACTS.

 

CROSSROADS SYSTEMS, INC.

COMMON STOCK PURCHASE WARRANT

To Purchase ______ Shares of Common Stock

 

	 	Date of Issuance:  April __, 2014
	 	 	 
	 	Warrant No.: ______

 

 

VOID
AFTER April [●], 2019

 

THIS CERTIFIES THAT,
for value received, [__], or permitted registered assigns (the “Holder”), is entitled to subscribe for
and purchase at the Exercise Price (defined below) from Crossroads Systems, Inc., a Delaware corporation (the “Company”),
up to [__] shares of the common stock of the Company, par value $0.001 per share (the “Common
Stock”). This warrant is one of a series of warrants issued by the Company as of the date hereof (individually,
a “Warrant”, and collectively, “Company
Warrants”) pursuant to that certain Securities Purchase Agreement between the Company and the parties signatory
thereto, dated as of March 31, 2014 (the “Securities Purchase
Agreement”). The Holder takes this Warrant subject to the terms and restrictions set forth in the Transaction
Documents (as defined in the Securities Purchase Agreement) and shall be entitled to certain rights and privileges as set forth
in the Transaction Documents.

 

1.          Definitions.
Capitalized terms used herein but not otherwise defined herein shall have their respective meanings as set forth in the Securities
Purchase Agreement. As used herein, the following terms shall have the following respective meanings:

 

(a)          “Exercise
Period” shall mean the period commencing with the date that is six months after the Closing Date and ending
on the fifth anniversary of the Closing Date, unless sooner terminated as provided below.

 

(b)          “Exercise
Price” shall initially mean $[__] per share, subject to adjustment pursuant to Section 5 below.

 

    	 

    	 

    

  

(c)          “Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company,
joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically
listed herein. 

 

(d)          
“Trading Day” shall mean any day on which
the principal Trading Market is open for business.

 

(e)          “Trading
Market” shall mean any of the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market, the New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).

 

(f)          “Warrant
Shares” shall mean the shares of Common Stock issuable upon exercise of this Warrant.

 

2.          Exercise
of Warrant.

 

2.1           Exercise
Mechanics. The rights represented by this Warrant may, subject to Section 7 below, be exercised in whole or in
part at any time during the Exercise Period, by delivery of the following to the Company at its address set forth on the signature
page hereto (or at such other address as it may designate by notice in writing to the Holder):

 

(a)          A
complete and duly executed Notice of Exercise, by or for the benefit of the Holder, in the form attached hereto as Exhibit A;
and

 

(b)          Payment
of the Exercise Price either in cash or by check (subject to the limitations in Section 2.3 below), or pursuant to the “cashless
exercise” procedures set forth in Section 4 below.

 

Execution and delivery
of the Notice of Exercise shall have the same effect as cancellation of the portion of the original Warrant so exercised, and this
Warrant shall evidence the right to purchase the remaining number of Warrant Shares, if any. If requested by the Company, the Holder
agrees to provide this Warrant, or an affidavit of lost security, to the Company within a reasonable period after the delivery
of the Notice of Exercise.

 

Certificates for shares
purchased hereunder shall be transmitted by the transfer agent of the Company to the Holder by crediting the account of the Holder’s
prime broker with the Depository Trust Company through its Deposits and Withdrawal at Custodian (DWAC) system if the Company is
a participant in such system, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise
within three (3) business days from the delivery to the Company of the Notice of Exercise, surrender of this Warrant and payment
of the aggregate Exercise Price as set forth above. This Warrant shall be deemed to have been exercised on the date the Exercise
Price is received by the Company. The Warrant Shares shall be deemed to have been issued, and the Holder or any other person so
designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date
this Warrant has been exercised by payment to the Company of the Exercise Price. If by the close of the third full Trading Day
after delivery of a Notice of Exercise, the Company fails to deliver to the Holder a certificate representing the required number
of Warrant Shares in the manner required pursuant to this Section 2, and if after such third Trading Day and prior to the
receipt of such Warrant Shares, the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”),
then the Company shall, within three Trading Days after the Holder’s request and in the Holder’s sole discretion, either
(a) pay in cash to the Holder an amount equal to the Holder’s total purchase price (including brokerage commissions, if any)
for the shares of Common Stock so purchased (the “Buy-In Price”),
at which point the Company’s obligation to deliver such certificate (and to issue such Warrant Shares) shall terminate or
(b) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Warrant Shares and pay
cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (i) such number of Warrant
Shares, times (ii) the closing bid price on the date of the event giving rise to the Company’s obligation to deliver such
certificate.

 

    	2

    	 

    

  

The person in whose
name any Warrant Shares are to be issued upon exercise of this Warrant shall be deemed to have become the holder of record of such
shares on the date on which this Warrant was surrendered and payment of the Exercise Price was made, irrespective of the date of
delivery of such certificate or certificates, except that, if the date of such surrender and payment is a date when the stock transfer
books of the Company are closed, such person shall be deemed to have become the holder of such shares at the close of business
on the next succeeding date on which the stock transfer books are open.

 

To the extent permitted
by law, the Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and
unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to
any provision hereof, the recovery of any judgment against any person or entity or any action to enforce the same, or any setoff,
counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other person or entity
of any obligation to the Company or any violation or alleged violation of law by the Holder or any other person or entity, and
irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with
the issuance of Warrant Shares.

 

Nothing herein shall
limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates
representing the Warrant Shares upon exercise of this Warrant as required pursuant to the terms hereof.

 

2.2           Issuance
of New Warrants. Upon any partial exercise of this Warrant, the Company, at its expense, will forthwith and, in any event within
five (5) business days, issue and deliver to the Holder a new warrant or warrants of like tenor, registered in the name of the
Holder, exercisable, in the aggregate, for the balance of the number of the Warrant Shares remaining available for purchase under
this Warrant.

 

    	3

    	 

    

  

2.3           Exercise
Limitations; Holder’s Restrictions. Notwithstanding anything in this Warrant or the Securities Purchase Agreement to
the contrary, a Holder who is not as of the date hereof subject to, or affiliated with a Person that is subject to, obligations
to report transactions in the Company’s securities under Section 16 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), shall not have the right to exercise any portion of this Warrant, pursuant to Section
2 or otherwise, to the extent that after giving effect to such issuance after exercise, such Holder (together with such Holder’s
affiliates), as set forth on the applicable Notice of Exercise, would beneficially own in excess of 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to such issuance, unless the Holder of this Warrant elects to waive
the provisions of this Section 2.3 upon not less than 61 days’ prior notice to the Company; provided, however,
that in no event shall any Holder have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise,
to the extent that after giving effect to such issuance after exercise, such Holder (together with such Holder’s affiliates),
as set forth on the applicable Notice of Exercise, would beneficially own in excess of 19.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to such issuance. For purposes of the foregoing sentence, the number of shares
of Common Stock beneficially owned by such Holder and its affiliates shall include the number of shares of Common Stock issuable
upon exercise of this Warrant if this Warrant is exercisable for shares of Common Stock with respect to which the determination
of such sentence is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (a) exercise
of the remaining, non-exercised portion of this Warrant beneficially owned by such Holder or any of its affiliates and (b) exercise
or conversion of the unexercised or non-converted portion of any other securities of the Company (including, without limitation,
any other shares of Common Stock or Warrants) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by such Holder or any of its affiliates. Except as set forth in the preceding sentence, for purposes
of this Section 2.3, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the
rules and regulations promulgated thereunder, it being acknowledged by a Holder that the Company is not representing to such Holder
that such calculation is in compliance with Section 13(d) of the Exchange Act and such Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2.3 applies, the
determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which portion
of this Warrant is exercisable shall be in the sole discretion of a Holder, and the submission of a Notice of Exercise shall be
deemed to be each Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by
such Holder) and of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Section
2.3, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares
of Common Stock as reflected in (x) the Company’s most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K,
as the case may be, filed with the SEC, (y) a more recent public announcement by the Company or (z) any other notice by the Company
or the Company’s transfer agent setting forth the number of shares of Common Stock outstanding. Upon its receipt of the written
or oral request of a Holder, the Company shall within two (2) Trading Days of such receipt confirm orally and in writing to such
Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by such Holder
or its affiliates since the date as of which such number of outstanding shares of Common Stock was reported.

 

    	4

    	 

    

  

3.          Covenants
of the Company.

 

3.1           Due
Authorization. The Company covenants and agrees that all Warrant Shares that may be issued upon the exercise of the rights
represented by this Warrant will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from
all taxes, liens and charges with respect to the issuance thereof.

 

3.2           Available
Shares. The Company covenants and agrees that the Company will, at all times during the Exercise Period, have authorized and
reserved, free from preemptive rights, a sufficient number of shares of Common Stock to provide for the exercise of the rights
represented by this Warrant. During the Exercise Period, if the number of authorized but unissued shares of Common Stock shall
not be sufficient to permit exercise of this Warrant into the applicable Warrant Shares, the Company will take such corporate action
as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number
of shares as shall be sufficient for such purposes.

 

3.3           Registration
Rights. The Holder and any permitted assignee or transferee of the Holder shall have the registration rights specified in the
Registration Rights Agreement.

 

3.4           No
Impairment. Except and to the extent as waived or consented to by the Holder, the Company will not, by amendment of its Certificate
of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed
hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant
and in the taking of all such action as may be necessary or appropriate in order to protect the exercise rights of the Holder against
impairment.

 

4.          Cashless
Exercise. If this Warrant is (a) exercisable for Warrant Shares and (b) if at any such time there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant
may also be exercised at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive
a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) =the VWAP on
the Trading Day immediately preceding the date of such election;

 

(B) =the Exercise
Price of this Warrant, as adjusted; and

 

(X) =the number
of Warrant Shares issuable upon exercise of this Warrant in accordance with the terms of this Warrant by means of a cash exercise
rather than a cashless exercise.

 

    	5

    	 

    

  

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then
listed or quoted on the principal Trading Market, the daily volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on the principal Trading Market on which the Common Stock is then listed or quoted for trading as reported
by Bloomberg (as defined below) (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time);
(b) if the Common Stock is not then quoted for trading on a Trading Market and if prices for the Common Stock are then reported
in the “Pink Sheets” published by OTC Markets Group Inc. (or a similar organization or agency succeeding to its functions
of reporting prices), the most recent bid price per share of the Common Stock so reported; or (c) in all other cases, the fair
market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of Company
Warrants representing at least a majority of the Warrant Shares then subject to outstanding Company Warrants and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.

 

5.          Adjustment
of Exercise Price and Shares.

 

5.1           Stock
Dividends, Split-Ups, Recapitalizations, Etc. In the event of changes in the outstanding Common Stock of the Company by reason
of stock dividends, split-ups, recapitalizations, reclassifications, combinations or exchanges of shares, separations, reorganizations,
liquidations, consolidation, acquisition of the Company (whether through merger or acquisition of substantially all the assets
or stock of the Company), or the like, the number, class and type of shares available under this Warrant in the aggregate and the
Exercise Price shall be correspondingly adjusted to give the Holder of this Warrant, on exercise for the same aggregate Exercise
Price, the total number, class, and type of shares or other property as the Holder would have owned had this Warrant been exercised
prior to the event and had the Holder continued to hold such shares until the event requiring adjustment. The form of this Warrant
need not be changed because of any adjustment in the number of Warrant Shares subject to this Warrant.

 

5.2           Certificate
of Adjustment. Upon the occurrence of each adjustment pursuant to this Section 5, the Company at its expense will, at
the written request of the Holder, promptly compute such adjustment in accordance with the terms of this Warrant and prepare a
certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of
Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise
to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will
promptly deliver a copy of each such certificate to the Holder and to the Company’s transfer agent.

 

6.          Fractional
Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment pursuant
hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining
whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise would result in
the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled
to such fraction a sum in cash equal to the product resulting from multiplying the then current Fair Market Value of a share of
Common stock by the fractional share not to be issued. “Fair Market Value” of one share of Common Stock
shall mean (a) the average of the closing sales prices for the shares of Common Stock on the principal Trading Market as reported
by Bloomberg Financial Markets (or a comparable reporting service of national reputation selected by the Company and reasonably
acceptable to the Holder if Bloomberg Financial Markets is not then reporting sales prices of such security) (collectively, “Bloomberg”)
for the ten (10) consecutive trading days immediately preceding such date, or (b) if the foregoing does not apply, the last sales
price of such security in the over-the-counter market on the pink sheets or bulletin board for such security as reported by Bloomberg,
or if no sales price is so reported for such security, the last bid price of such security as reported by Bloomberg, or (c) if
Fair Market Value cannot be calculated as of such date on either of the forgoing bases, the Fair Market Value shall be as determined
by the Board of Directors of the Company (or a duly constituted committee thereof) in the exercise of its good faith judgment.

 

    	6

    	 

    

  

7.          Fundamental
Transactions. If, at any time while this Warrant is outstanding, (a) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (b) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets
in one or a series of related transactions, (c) any direct or indirect purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding shares
of Common Stock, (d) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (e) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the
outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or
party to, or associated or affiliated with the Persons making or party to, such stock or share purchase agreement or other business
combination) (each, a “Fundamental Transaction”),
then, subject to the last sentence of this Section, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such
Fundamental Transaction, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and any additional consideration (the “Alternate
Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction. For purposes of any such
exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based
on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding the foregoing,
if at any time while this Warrant is outstanding, the Company engages in any Fundamental Transaction in which the holders of Common
Stock receive in exchange for their shares of Common Stock only cash, then the Holder of this Warrant shall be entitled to receive
only an amount of cash equal to (i) (A) the amount of cash payable in such Fundamental Transaction to the holders of Common Stock
for each share of Common Stock held by the Holder of this Warrant; less (B) the Exercise Price of this Warrant, as adjusted; multiplied
by (ii) the number of Warrant Shares issuable upon exercise of this Warrant, at the same time and on the same terms as the holders
of Common Stock, and immediately upon the receipt of such payment by the Holder this Warrant shall terminate.

 

    	7

    	 

    

  

8.          No
Stockholder Rights. Other than as provided herein, this Warrant in and of itself shall not entitle the Holder to any voting
rights or other rights as a stockholder of the Company.

 

9.          Transfer
of Warrant. Subject to compliance with any applicable laws, this Warrant and all rights hereunder are transferable, by the
Holder in person or by duly authorized attorney, only upon delivery of this Warrant and the form of assignment attached hereto
as Exhibit B to any transferee designated by the Holder. The transferee shall sign an investment letter in form and substance
reasonably satisfactory to the Company and its counsel.

 

10.         Lost,
Stolen, Mutilated or Destroyed Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms
as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender
thereof for cancellation at the office of the Company), issue a new Warrant of like denomination and tenor as this Warrant so lost,
stolen, mutilated or destroyed. Any such new Warrant shall constitute an original contractual obligation of the Company, whether
or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone.

 

11.         Notices,
Etc. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal
delivery to the party to be notified, (b) when sent by electronic transmission or facsimile if sent during normal business hours
of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying
next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address listed
on the signature page hereto to the attention of the Chief Financial Officer (with a copy to Andrews Kurth LLP, Attn: J. Matthew
Lyons, Fax: (512) 320-9292, Email: mlyons@andrewskurth.com) and to the Holder at the applicable address set forth on the applicable
signature page to the Securities Purchase Agreement or at such other address as the Company or the Holder may designate by ten
(10) days advance written notice to the other parties hereto.

 

12.         Acceptance.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained
herein.

 

13.         Governing
Law; Venue; Waiver of Jury Trial. This Warrant shall be governed by, and construed in accordance with, the laws of the State
of Delaware. The Holder hereby submits to the non-exclusive jurisdiction of the federal and state courts in the City of Wilmington,
Delaware in any suit or proceeding arising out of or relating to this Warrant or the transactions contemplated thereby. The Holder
irrevocably and unconditionally waives any objection to the laying of venue of any suit or proceeding arising out of or relating
to this Warrant in federal and state courts in the City of Wilmington, Delaware and irrevocably and unconditionally waives and
agrees not to plead or claim in any such court that any such suit or proceeding in any such court has been brought in an inconvenient
forum. The Holder hereby irrevocably waives any right it may have, and agrees not to request, a jury trial for the adjudication
of any dispute hereunder or in connection with or arising out of this Warrant.

 

    	8

    	 

    

  

14.         Interpretation.
All parties have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question
of intent or interpretation arises, this Agreement shall be construed as jointly drafted by all of the parties and no presumption
or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Warrant.

 

15.         Amendment
or Waiver. Any term of this Warrant may be amended or waived (either generally or in a particular instance and either retroactively
or prospectively) only by an instrument in writing signed by the Company and the Holder. No waivers of any term, condition or provision
of this Warrant, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such
term, condition or provision.

 

[Remainder of Page Intentionally Left
Blank]

 

    	9

    	 

    

  

IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its duly authorized officer as of April __, 2014.

 

	 	CROSSROADS SYSTEMS, INC.
	 	 
	 	By:	 
	 	 
	 	Name:	 
	 	 
	 	Title:	 

 

[Signature Page to Common Stock Purchase Warrant]

 

    	 

    	 

    

  

EXHIBIT
A

 

NOTICE OF EXERCISE

 

TO: CROSSROADS SYSTEMS, INC.

 

(1)         The
undersigned hereby elects to purchase __________shares of the common stock, par value $0.001 (the “Common
Stock”), of Crossroads Systems, Inc. (the “Company”)
pursuant to the terms of the attached Warrant, and tenders herewith payment of the applicable exercise price in full, together
with all applicable transfer taxes, if any, subject to the limitations set forth in Section 2.3 of the Warrant.

 

(2)         Please
issue the certificate for shares of Common Stock in the name of, and pay any cash for any fractional share to:

 

	 	 	 
	 	(Print or type name)	 
	 	 	 
	 	 	 
	 	(Social Security or other Identifying Number)	 
	 	 	 
	 	 	 
	 	(Street Address)	 
	 	 	 
	 	 	 
	 	(City, State, Zip Code)	 

  

(3)         If
such number of shares shall not be all the shares purchasable upon the exercise of the Warrants evidenced by this Warrant, a new
warrant certificate for the balance of such Warrants remaining unexercised shall be registered in the name of and delivered to:

 

Please insert Social
Security or other identifying number: ____________________

 

(Please print name and address)

 

	 	 	 
	Dated:	 	 	 
	(Date)	 	(Signature)
	 	 	 
	 	 	 
	 	 	(Print Name)

 

    	Exhibit A

    	 

    

  

EXHIBIT
B

 

ASSIGNMENT FORM

 

(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 
	 	(Please Print)
	 	 
	Address:	 
	 	 
	 	(Please Print)
	 	 
	Dated:	_____________________, 20__
	 	 
	Holder’s Signature:	 
	 	 
	Holder’s Address:	 
	 	 

 

 

NOTE: The signature to this Assignment
Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatever.
Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority
to assign the foregoing Warrant.

 

 

    	Exhibit BExhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE
AGREEMENT (the “Agreement”) is dated as of the 4th day of April, 2014 (the “Effective Date”),
by and between CROSSROADS SYSTEMS, INC., a Delaware corporation (the “Company”), and each individual
or entity named on the Schedule A attached hereto (each such individual or entity, individually, a “Buyer”
and all of such individuals or entities, collectively, the “Buyers”). Capitalized terms used herein shall
have the meanings set forth in Article II of this Agreement.

 

RECITALS

 

WHEREAS, the Company
and each Buyer is executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the “Securities Act”),
including Regulation D, by the U.S. Securities and Exchange Commission (the “SEC”);

 

WHEREAS, each Buyer
desires to purchase from the Company, upon the terms and conditions stated in this Agreement, (i) one newly issued share (each,
a “Common Share” and, collectively, the “Common Shares”) of common stock of
the Company, par value $0.001 per share (“Common Stock”), and (ii) a warrant to purchase a number
of Common Shares equal to one-half of the number of Common Shares purchased, in substantially the form attached hereto as Exhibit
A (each, a “Warrant” and, collectively, the “Warrants” and, Common
Share together with a Warrant to purchase one-half of a Common Share, a “Unit” and, collectively, the
“Units”) with an exercise price of $2.35 per Warrant Share, each Buyer hereby purchasing the number of
Units as set forth opposite such Buyer’s name in Schedule A hereto, all of which Units shall be purchased on the date
hereof (the “Closing Date”), for the purchase price of Two and 25.65/100 Dollars ($2.2565) per Unit (the
“Per-Unit Purchase Price”), and all otherwise subject to the terms and provisions hereinafter set forth;
and

 

WHEREAS, contemporaneously
with the execution and delivery of this Agreement, the parties hereto are executing and delivering an Amended and Restated Registration
Rights Agreement, substantially in the form attached hereto as Exhibit B (the “Registration Rights Agreement”),
pursuant to which the Company has agreed to provide certain registration rights to the Buyers under the Securities Act, and applicable
state securities laws.

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants of the parties hereinafter expressed and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties hereto, each intending to be legally bound, agree as follows:

 

ARTICLE
I

RECITALS,
EXHIBITS, SCHEDULES

 

The foregoing recitals,
together with the Schedules, Exhibits and disclosure letter referred to hereafter, are hereby incorporated into this Agreement
by this reference.

 

ARTICLE
II

DEFINITIONS

For purposes of this
Agreement, except as otherwise expressly provided or otherwise defined elsewhere in this Agreement, the capitalized terms in this
Agreement shall have the meanings assigned to them in this Article as follows:

 

    	 

    	 

    

 

2.1            “8-K
Filing” shall have the meaning set forth in Section 7.7 of this Agreement.

 

2.2            “Affiliate”
means, with respect to a Person, any other Person directly or indirectly controlling, controlled by, or under common control with,
such Person at any time during the period for which the determination of affiliation is being made. For purposes of this definition,
the term “control,” “controlling,” “controlled” and
words of similar import, when used in this context, means, with respect to any Person, the possession, directly or indirectly,
of the power to direct, or cause the direction of, management policies of such Person, whether through the ownership of voting
securities, by contract or otherwise; provided, however, in no event shall any Buyer be deemed an Affiliate of the
Company for purposes of this Agreement.

 

2.3            “AK”
shall have the meaning set forth in Section 12.19 of this Agreement.

 

2.4            “Assets”
means all of the properties and assets of the Company or of the Subsidiaries, whether real, personal or mixed, tangible or intangible,
wherever located, whether now owned or hereafter acquired.

 

2.5           
“Buyer” shall have the meaning set forth in the introductory paragraph of this Agreement.

 

2.6            “Buyer
Indemnified Parties” shall have the meaning set forth in Section 10.1 of this Agreement.

 

2.7            “Buyer
Representatives” shall have the meaning set forth in Section 11.1 of this Agreement.

 

2.8            “Bylaws”
shall have the meaning set forth in Section 6.4 of this Agreement.

 

2.9            “Certificate
of Incorporation” shall have the meaning set forth in Section 6.4 of this Agreement.

 

2.10          “Claims”
means any Proceedings, Judgments, Obligations, threats, losses, damages, deficiencies, settlements, assessments, charges, costs
and expenses of any nature or kind.

 

2.11          “Closing”
shall have the meaning set forth in Section 4.2 of this Agreement.

 

2.12          “Closing
Date” shall have the meaning set forth in the Recitals of this Agreement.

 

2.13          “Committee”
shall have the meaning set forth in Section 9.5 of this Agreement.

 

2.14          “Common
Shares” shall have the meaning set forth in the Recitals of this Agreement.

 

2.15          “Common
Stock” shall have the meaning set forth in the Recitals of this Agreement.

 

2.16          “Company”
shall have the meaning set forth in the introductory paragraph of this Agreement.

 

2.17          “Company
Balance Sheet” shall have the meaning set forth in Section 6.10 of this Agreement.

 

    	2

    	 

    

 

2.18          “Company
Leases” shall have the meaning set forth in Section 6.12(b) of this Agreement.

 

2.19          “Consent”
means any consent, approval, order or authorization of, or any declaration, filing or registration with, or any application or
report to, or any waiver by, or any other action (whether similar or dissimilar to any of the foregoing) of, by or with, any Person,
which is necessary in order to take a specified action or actions, in a specified manner and/or to achieve a specific result.

 

2.20          “Contract”
means any written or oral contract, agreement, order or commitment of any nature whatsoever, including, any sales order, purchase
order, lease, sublease, license agreement, services agreement, loan agreement, mortgage, security agreement, guarantee, management
contract, employment agreement, consulting agreement, partnership agreement, stockholders agreement, buy-sell agreement, option,
warrant, debenture, subscription, call or put.

 

2.21          “DRS”
means the Direct Registration System maintained by the transfer agent for the Common Stock.

 

2.22          “Effective
Date” means the date set forth in the introductory paragraph of this Agreement.

 

2.23          “Encumbrance”
means any lien, security interest, pledge, mortgage, easement, leasehold, assessment, tax, covenant, reservation, conditional sale,
prior assignment, or any other encumbrance, claim, burden or charge of any nature whatsoever.

 

2.24          “Environmental
Requirements” means all Laws and requirements relating to human, health, safety or protection of the environment
or to emissions, discharges, releases or threatened releases of pollutants, contaminants, or Hazardous Materials in the environment
(including, without limitation, ambient air, surface water, ground water, land surface or subsurface strata), or otherwise relating
to the treatment, storage, disposal, transport or handling of any Hazardous Materials.

 

2.25          “ERISA”
shall have the meaning set forth in Section 6.17 of this Agreement.

 

2.26          “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

2.27          “Financial
Advisor” shall have the meaning set forth in Section 6.27 of this Agreement.

 

2.28          “Financial
Statements” shall have the meaning set forth in Section 6.7 of this Agreement.

 

2.29          “GAAP”
means generally accepted accounting principles, methods and practices set forth in the opinions and pronouncements of the Accounting
Principles Board and the American Institute of Certified Public Accountants, and statements and pronouncements of the Financial
Accounting Standards Board, in each case as of the date or period at issue, and as applied in the U.S. to U.S. companies.

 

2.30          “Governmental
Authority” means any foreign, federal, state or local government, or any political subdivision thereof, or any court,
agency or other body, organization, group, stock market or exchange exercising any executive, legislative, judicial, quasi-judicial,
regulatory or administrative function of government.

 

    	3

    	 

    

 

2.31          “Hazardous
Materials” means: (i) any petroleum or petroleum products, radioactive materials, asbestos in any form that is or
could become friable, urea formaldehyde foam insulation and transformers or other equipment that contain dielectric fluid containing
levels of polychlorinated biphenyls (PCBs); (ii) any chemicals, materials, substances or wastes which are now or hereafter become
defined as or included in the definition of “hazardous substances,” “hazardous wastes,” “hazardous
materials,” “extremely hazardous wastes,” “restricted hazardous wastes,” “toxic substances,”
“toxic pollutants” or words of similar import, under any Law; and (iii) any other chemical, material, substance, or
waste, exposure to which is now or hereafter prohibited, limited or regulated by any Governmental Authority.

 

2.32          “Insurance
Policies” shall have the meaning set forth in Section 6.19 of this Agreement.

 

2.33          “Judgment”
means any order, writ, injunction, fine, citation, award, decree, or any other judgment of any nature whatsoever of any Governmental
Authority.

 

2.34          “Law”
means any provision of any law, statute, ordinance, code, constitution, charter, treaty, rule or regulation of any Governmental
Authority.

 

2.35          “Leases”
means all leases for real or personal property.

 

2.36          “Majority” means one or more Buyers whose respective ownership of shares of the Common Shares issued
hereby held by such Buyers, as of the relevant date, aggregates at a majority of the aggregate number of shares of Common Shares
issued pursuant hereto that are outstanding on such date and continue to be held by the Buyers.

 

2.37          “Material
Adverse Effect” means with respect to the event, item or question at issue, that such event, item or question would
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of this
Agreement or any of the Transaction Documents; (ii) a material adverse effect on the results of operations, Assets, business or
condition (financial or otherwise) of the Company and its consolidated Subsidiaries, taken as a whole; or (iii) a material adverse
effect on the Company’s ability to perform, on a timely basis, its Obligations under this Agreement or any Transaction Documents;
provided, however, that no action by the Trading Market with respect to the listing of the Company’s Common
Stock that is taken as a result of the circumstances described by the Company’s Form 8-K filed on September 24, 2013 shall
be considered a “Material Adverse Effect” for purposes of this Agreement, it being understood that on March 21, 2014,
the Company received a notice that the current Trading Market had determined to delist its securities based on the stockholders’
equity deficiency unless the Company requests a hearing before the Listing Qualifications Panel within seven days from the date
of the notice.

 

2.38          “Material
Contract” means, as to any Person, any agreement filed or required to be filed with the SEC pursuant to applicable
securities law.

 

2.39          “Material
Shareholder” shall have the meaning set forth in Section 6.23 of this Agreement.

 

2.40          “Obligation”
means any debt, liability or obligation of any nature whatsoever, whether secured, unsecured, recourse, nonrecourse, liquidated,
unliquidated, accrued, absolute, fixed, contingent, ascertained, unascertained, known, unknown or obligations under executory Contracts.

 

2.41          “OFAC”,
shall have the meaning set forth in Section 12.18 of this Agreement.

 

    	4

    	 

    

 

2.42          “Ordinary
Course of Business” means the ordinary course of business consistent with past custom and practice (including with
respect to quantity, quality and frequency).

 

2.43          “Per-Unit
Purchase Price” shall have the meaning set forth in the Recitals.

 

2.44          “Permit”
means any license, permit, approval, waiver, order or authorization granted, issued or approved by any Governmental Authority.

 

2.45          “Person”
means any individual, sole proprietorship, joint venture, partnership, company, corporation, association, cooperation, trust, estate,
Governmental Authority, or any other entity of any nature whatsoever.

 

2.46          “Preferred
Stock” shall have the meaning set forth in Section 6.4 of this Agreement.

 

2.47          “Proceeding”
means any demand, claim, suit, action, litigation, investigation, audit, study, arbitration, administrative hearing, or any other
proceeding of any nature whatsoever.

 

2.48          “Purchase
Price” shall have the meaning set forth in Section 4.1 of this Agreement.

 

2.49          “Real
Property” means any real estate, land, building, structure, improvement, fixture or other real property of any nature
whatsoever, including, but not limited to, fee and leasehold interests.

 

2.50          “Registration
Rights Agreement” shall have the meaning set forth in the Recitals of this Agreement.

 

2.51          “Rule
144” shall have the meaning set forth in Section 7.3(e) of this Agreement.

 

2.52          “Rule
144 Certificate” shall have the meaning set forth in Section 7.3(e)(C) of this Agreement.

 

2.53          “SEC”
shall have the meaning set forth in the Recitals of this Agreement.

 

2.54          “SEC
Documents” shall have the meaning set forth in Section 6.7 of this Agreement.

 

2.55          “Securities”
means, collectively, the Units, the Common Shares, the Warrants and the Warrant Shares.

 

2.56          “Securities
Act” shall have the meaning set forth in the Recitals of this Agreement.

 

2.57          “Securities
Being Sold” shall have the meaning set forth in Section 7.3(e)(C) of this Agreement.

 

2.58          “Series
A Preferred Stock” shall have the meaning set forth in Section 6.4 of this Agreement.

 

2.59          “Series
F Certificate of Designation” shall have the meaning set forth in Section 6.4 of this Agreement.

 

2.60          “Series
F Preferred Stock” shall have the meaning set forth in Section 6.4 of this Agreement.

 

    	5

    	 

    

 

2.61          “Share
Reserve” shall have the meaning set forth in Section 7.5 of this Agreement.

 

2.62          “Shell
Company” shall have the meaning set forth in Section 7.3(e) of this Agreement.

 

2.63          “Short
Sales” shall have the meaning set forth in Section 5.12 of this Agreement.

 

2.64          “Subsidiaries”
means collectively each of the following: Crossroads Systems (Texas), Inc., a Texas corporation, NexQL Corporation, a Delaware
corporation, and Crossroads Europe GmbH, a Gesellschaft mit beschränkter Haftung under the laws of Germany (“Crossroads
Europe”).

 

2.65          “Tax”
means (i) any foreign, federal, state or local income, profits, gross receipts, franchise, sales, use, occupancy, general property,
real property, personal property, intangible property, transfer, excise, accumulated earnings, unemployment compensation, social
security, withholding taxes, payroll taxes, or any other tax of any nature whatsoever, (ii) any foreign, federal, state or local
organization fee, qualification fee, annual report fee, filing fee, occupation fee, or assessment, or (iii) any deficiency, interest
or penalty imposed with respect to any of the foregoing.

 

2.66          “Tax
Return” means any tax return, filing, declaration, information statement or other form or document required to be
filed in connection with or with respect to any Tax.

 

2.67          “Trading
Market” means any of the following markets or exchanges on which the Common stock is listed or quoted for trading
on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).

 

2.68          “Transaction
Documents” means any documents or instruments to be executed by the Company in connection with this Agreement, including
the Common Shares, the Warrants and the Registration Rights Agreement, together with all modifications, amendments, extensions,
future advances, renewals, and substitutions thereof.

 

2.69          “Units”
shall have the meaning set forth in the Recitals of this Agreement.

 

2.70          “Warrants”
shall have the meaning set forth in the Recitals of this Agreement.

 

2.71          “Warrant
Shares” means the shares of Common Stock issuable upon exercise of the Warrants.

 

ARTICLE
III

INTERPRETATION

 

In this Agreement,
unless the express context otherwise requires: (i) the words “herein,” “hereof” and “hereunder”
and words of similar import refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) references
to the words “Article” or “Section” refer to the respective Articles and Sections of this Agreement, and
references to “Exhibit” or “Schedule” refer to the respective Exhibits and Schedules annexed hereto; (iii)
references to a “party” mean a party to this Agreement and include references to such party’s permitted successors
and permitted assigns; (iv) references to a “third party” mean a Person not a party to this Agreement; (v) the terms
“dollars” and “$” means U.S. dollars; (vi) wherever the word “include,” “includes”
or “including” is used in this Agreement, it will be deemed to be followed by the words “without limitation.”

 

    	6

    	 

    

 

ARTICLE
IV

PURCHASE
AND SALE OF UNITS

 

4.1            Purchase
and Sale of Units. Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, Buyers agree to purchase
the Units (each Buyer hereby agreeing, severally and not jointly, to purchase the number of Units set forth opposite such Buyer’s
name on Schedule A attached hereto), on the Closing Date, and the Company agrees to sell and issue to Buyers the Units (the
Company hereby agreeing to issue the number of Units to each Buyer set forth opposite such Buyer’s name on Schedule A
attached hereto), on the Closing Date for an amount equal to the Per-Unit Purchase Price multiplied by the number of Units purchased
(the “Purchase Price”), all as set forth in more detail on Schedule A and as more specifically
set forth below.

 

4.2            Closing.
The closing of the purchase and sale of the Units (the “Closing”) shall take place on the Closing Date,
subject to satisfaction of the conditions to the Closing set forth in this Agreement.

 

4.3            Form
of Payment. Subject to the satisfaction of the terms and conditions of this Agreement, on the Closing Date: (i) each Buyer
shall deliver to the Company, in the form of a wire transfer, immediately available funds equal to the portion of the Purchase
Price applicable to such Buyer (such amount shall be based on the number of Units set forth opposite such Buyer’s name on
Schedule A attached hereto), and (ii) the Company shall deliver to Buyers the Securities which Buyers are purchasing hereunder
at the Closing, duly executed on behalf of the Company, together with any other documents required to be delivered pursuant to
this Agreement.

 

ARTICLE
V

REPRESENTATIONS
AND WARRANTIES OF THE BUYERS

 

Each Buyer represents and warrants to the
Company that:

 

5.1            Organization.
Each Buyer, if other than an individual, is duly organized and validly existing under the laws of the jurisdiction of its organization
and has all requisite corporate, partnership or limited liability company power and authority to invest in the Securities pursuant
to this Agreement, enter into and execute this Agreement and the Transaction Documents and to carry out the transactions contemplated
by this Agreement and the Transaction Documents.

 

5.2            Investment
Purpose. Each Buyer is acquiring the Securities for its own account for investment only and not with a view towards, or for
resale in connection with, the public sale or distribution thereof, except pursuant to sales registered or exempted under the Securities
Act; provided, however, that by making the representations herein, each Buyer reserves the right to dispose of the
Securities at any time in accordance with or pursuant to an effective registration statement covering such Securities or an available
exemption under the Securities Act.

 

    	7

    	 

    

 

5.3            Post-Transaction
Ownership. Each Buyer acknowledges that in accordance with Nasdaq Listing Rule 5635(b), that stockholder approval would be
required if, following the transactions contemplated hereby, such Buyer, together with its Affiliates, were to own more than 19.99%
of the total outstanding Common Stock of the Company or of the total voting power of the Company’s securities. Each Buyer
acknowledges that the transactions contemplated hereby are intended to be compliant with Nasdaq Listing Rules without the need
for Company stockholder approval, and represents and warrants to the Company that the purchase by such Buyer of the Securities
issuable to it at the Closing will not result in such Buyer (individually or together with other Person with whom such Buyer has
identified, or will have identified, itself as part of a “group” in a public filing made with the SEC involving the
Company’s securities) acquiring, or obtaining the right to acquire, in excess of 19.99% of the outstanding shares of Common
Stock or the voting power of the Company on a post transaction basis that assumes that the Closing shall have occurred. Such Buyer
does not presently intend to, alone or together with others, make a public filing with the Commission to disclose that it has (or
that it together with such other Persons have) acquired, or obtained the right to acquire, as a result of the Closing (when added
to any other securities of the Company that it or they then own or have the right to acquire), in excess of 19.99% of the outstanding
shares of Common Stock or the voting power of the Company on a post transaction basis that assumes that the Closing shall have
occurred.

 

5.4            Accredited
Buyer Status. Each Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D, as
promulgated under the Securities Act. Each Buyer acknowledges that it can bear the economic risk and complete loss of its investment
in the Securities and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits
and risks of the investment contemplated hereby.

 

5.5            Reliance
on Exemptions. Each Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities Laws and that the Company is relying upon the
truth and accuracy of, and each Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of each Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of
each Buyer to acquire the Securities.

 

5.6            Information.
Each Buyer and its advisors, if any, have had adequate opportunity to review the SEC Documents (as defined below) and have been
furnished with all other materials relating to the business, finances and operations of the Company and information each Buyer
deemed material to making an informed investment decision regarding its purchase of the Securities, which have been requested by
each Buyer. Each Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company and its management.
Neither such inquiries, nor any other due diligence investigations conducted by any Buyer or its advisors, if any, or its representatives,
shall modify, amend or affect each Buyer’s right to rely on the Company’s representations and warranties contained
in Article VI below. Each Buyer understands that its investment in the Securities involves a high degree of risk. Each Buyer is
in a position regarding the Company, which, based upon employment, other relationship or economic bargaining power, enabled and
enables such Buyer to obtain information from the Company in order to evaluate the merits and risks of this investment. Each Buyer
has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect
to its acquisition of the Securities.

 

5.7            No
Governmental Review. Each Buyer understands that no United States federal or state Governmental Authority has passed on or
made any recommendation or endorsement of the Securities, or the fairness or suitability of the investment in the Securities, nor
have such Governmental Authorities passed upon or endorsed the merits of the offering of the Securities.

 

5.8            Authorization,
Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of each Buyer and is a valid
and binding agreement of each Buyer, enforceable in accordance with its terms, except as such enforceability may be limited by
general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws
relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

    	8

    	 

    

 

5.9            Restrictions
on Transferability. Each Buyer understands that because the Securities have not have been registered under the Securities Act,
the Buyer cannot dispose of any or all of the Securities unless they are subsequently registered under the Securities Act or exemptions
from registration are available. Each Buyer acknowledges and understands that, except as provided in the Registration Rights Agreement,
it has no registration rights. Although it may be possible in the future to make limited public sales of the Securities without
registration under the Securities Act, Rule 144 is not now available and there is no assurance that it will become available for
any purpose. By reason of these restrictions, each Buyer understands that it may be required to hold the Securities for an indefinite
period of time. Each Buyer understands that each certificate or other instrument representing the Securities will bear appropriate
state “blue sky” legends and a legend substantially as follows:

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER EITHER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”),
OR APPLICABLE STATE SECURITIES LAWS (THE “STATE ACTS”), AND SHALL NOT BE SOLD, ASSIGNED, PLEDGED, HYPOTHECATED, DONATED
OR OTHERWISE TRANSFERRED (WHETHER OR NOT FOR CONSIDERATION) BY THE HOLDER EXCEPT BY REGISTRATION OR PURSUANT TO AN EXEMPTION FROM
REGISTRATION UPON THE ISSUANCE TO THE COMPANY OF A FAVORABLE OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE
COMPANY TO THE EFFECT THAT ANY SUCH TRANSFER SHALL NOT BE IN VIOLATION OF THE 1933 ACT AND THE STATE ACTS”;

 

and appropriate transfer restrictions will
be affixed to any notation in the DRS for any Securities.

 

5.10          No
General Solicitation. Each Buyer did not learn of the investment in the Securities as a result of any general solicitation
or general advertising.

 

5.11          Brokers
and Finders. No Person will have, as a result of the transactions contemplated by the Transaction Documents, any valid right,
interest or claim against or upon the Company, any Subsidiary or a Buyer for any commission, fee or other compensation pursuant
to any agreement, arrangement or understanding entered into by or on behalf of such Buyer.

 

5.12          Certain
Transactions; Confidentiality. Other than consummating the transactions contemplated hereunder, such Buyer has not directly
or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Buyer, executed any purchases
or sales, including “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (“Short
Sales”), of the securities of the Company during the period commencing as of the time that such Buyer first received
a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of
the transactions contemplated hereby and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Buyer that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such
Buyer’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Buyer’s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.
Other than to other Persons party to this Agreement and its legal and accounting advisers, such Buyer has maintained the confidentiality
of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction).

 

    	9

    	 

    

 

5.13          No
Disqualification Events. Neither the Buyer nor, to the extent it has them, any of its shareholders, members, managers, general
or limited partners, directors, affiliates or executive officers (collectively with the Buyer, the “Buyer Covered Persons”),
are subject to any of the "bad actor" disqualifications described in Securities Act Rule 506(d)(1)(i) to (viii) (each,
a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).
The Buyer has exercised reasonable care to determine whether any Buyer Covered Person is subject to a Disqualification Event. The
purchase of the Units by the Buyer will not subject the Company to any Disqualification Event.

 

ARTICLE
VI

REPRESENTATIONS
AND WARRANTIES OF THE COMPANY

 

Except as set forth
and disclosed in the disclosure letter provided to the Buyers in connection with this Agreement and made a part hereof or as set
forth in the SEC Documents, the Company hereby makes the following representations and warranties to the Buyers:

 

6.1            Subsidiaries.
Except for a ninety-nine percent limited partner interest in KIP CR P1 LP, a ninety percent (90%) ownership in NexQL corporation
and a one hundred percent (100%) ownership in the other Subsidiaries, the Company has no subsidiaries and the Company does not
own, directly or indirectly, any outstanding voting securities of or other interests in, or have any control over, any other Person.
Each representation and warranty contained in this Article VI shall be deemed to mean and be construed to include the Company and
each Subsidiary, as applicable, regardless of whether each of such representations and warranties in Article VI specifically refers
to the Company’s Subsidiaries or not.

 

6.2            Organization.
Each of the Company and its Subsidiaries is a corporation or similar entity, duly organized, validly existing and in good standing
under the Laws of the jurisdiction in which it is incorporated or formed. The Company has the full corporate power and authority
and all necessary certificates, licenses, approvals and Permits to: (i) enter into and execute this Agreement and the Transaction
Documents and to perform all of its Obligations hereunder and thereunder; and (ii) own and operate its Assets and properties and
to conduct and carry on its business as and to the extent now conducted. The Company is duly qualified to transact business and
is in good standing as a foreign corporation in each jurisdiction where the character of its business or the ownership or use and
operation of its Assets or properties requires such qualification, except to the extent that failure to so qualify willnot result
in a Material Adverse Effect.

 

6.3            Authority
and Approval of Agreement; Binding Effect. The execution and delivery by the Company of this Agreement and the Transaction
Documents, and the performance by the Company of all of its Obligations hereunder and thereunder, including the issuance of the
Securities, have been duly and validly authorized and approved by the Company and its board of directors (or a duly authorized
committee thereof) pursuant to all applicable Laws and no other corporate action on the part of the Company, its board of directors,
stockholders or any other Person is necessary or required by the Company to execute this Agreement and the Transaction Documents,
consummate the transactions contemplated herein and therein, perform all of the Company’s Obligations hereunder and thereunder,
or to issue the Securities. This Agreement and each of the Transaction Documents have been duly and validly executed by the Company
(and the officer executing this Agreement and all such other Transaction Documents is duly authorized to act and execute same on
behalf of the Company) and constitute the valid and legally binding agreements of the Company, enforceable against the Company
in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the
enforcement of applicable creditors’ rights and remedies.

 

    	10

    	 

    

 

6.4            Capitalization.
The authorized capital stock of the Company consists of: (a) 75,000,000 shares of Common Stock, of which 14,770,845 shares of Common
Stock are issued and outstanding as of the end of the day prior to the Effective Date; and (b) 25,000,000 shares of Preferred Stock,
par value $0.001 per share (“Preferred Stock”), of which 175,000 shares are designated as Series A Convertible
Preferred Stock (“Series A Preferred Stock”), of which no shares of Series A Preferred Stock are issued
and outstanding as of the Effective Date and of which 4,500,000 shares are designed as 5.0% Series F Convertible Preferred Stock
(“Series F Preferred Stock”), of which 3,783,697 shares of Series F Preferred Stock are issued and outstanding
as of the Effective Date.  All outstanding shares of Common Stock have been validly issued and are fully paid and nonassessable.
The Common Stock is currently quoted on the principal Trading Market under the trading symbol “CRDS.” No shares of
Common Stock are subject to preemptive rights or any other similar rights or any Encumbrances suffered or permitted by the Company.
Except as contemplated hereby, as of the date hereof: (i) there are no outstanding options, warrants, scrip, rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital
stock of the Company or any of its Subsidiaries, or Contracts, commitments, understandings or arrangements by which the Company
or any of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries,
or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries; (ii) there are no outstanding
debt securities, notes, credit agreements, credit facilities or other Contracts or instruments evidencing indebtedness of the Company
or any of its Subsidiaries, or by which the Company or any of its Subsidiaries is or may become bound; (iii) there are no agreements
or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities
under the Securities Act (except pursuant to the Registration Rights Agreement); (iv) there are no financing statements securing
obligations filed in connection with the Company or any of its Assets; (v) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by this Agreement or any related agreement or the consummation of the transactions
described herein or therein; and (vi) there are no outstanding securities or instruments of the Company which contain any
redemption or similar provisions, and there are no Contracts by which the Company is or may become bound to redeem a security of
the Company. The Company has furnished or made available to the Buyer true, complete and correct copies of: (I) the Company’s
Certificate of Incorporation, as amended and as in effect on the date hereof (the “Certificate of Incorporation”),
including the Certificate of Designation of the Series F Preferred Stock (the “Series F Certificate of Designation”);
and (II) the Company’s Amended and Restated Bylaws, as in effect on the date hereof (the “Bylaws”).
Except for the Certificate of Incorporation, the Bylaws and the Series F Certificate of Designation, there are no other stockholders
agreements, voting agreements or other Contracts of any nature or kind that restrict, limit or in any manner impose Obligations
on the governance of the Company.

 

    	11

    	 

    

 

6.5            No
Conflicts; Consents and Approvals. The execution, delivery and performance of this Agreement and the Transaction Documents,
and the consummation of the transactions contemplated hereby and thereby, including the issuance of any of the Securities, will
not: (i) constitute a violation of or conflict with the Certificate of Incorporation, Bylaws, the Series F Certificate of Designation
or any other organizational or governing documents of the Company; (ii) constitute a violation of, or a default or breach under
(either immediately, upon notice, upon lapse of time, or both), or conflicts with, or gives to any other Person any rights of termination,
amendment, acceleration or cancellation of, any provision of any Contract to which the Company is a party or by which any of its
Assets or properties may be bound; (iii) constitute a violation of, or a default or breach under (either immediately, upon notice,
upon lapse of time, or both), or conflicts with, any Judgment; (iv) constitute a violation of, or conflict with, any Law (including
United States federal and state securities Laws and the rules and regulations of the principal Trading Market on which the Common
Stock is quoted); or (v) result in the loss or adverse modification of, or the imposition of any fine, penalty or other Encumbrance
with respect to, any Permit granted or issued to, or otherwise held by or for the use of, the Company or any of the Company’s
Assets; except, in the case of clauses (ii)–(v), for such violations, defaults, breaches, conflicts, losses, modifications
or impositions that have not had and would not reasonably be expected to have a Material Adverse Effect. The Company is not in
violation of its Certificate of Incorporation, Bylaws or other organizational or governing documents and the Company is not in
default or breach (and no event has occurred which with notice or lapse of time or both could put the Company in default or breach)
under, and the Company has not taken any action or failed to take any action that would give to any other Person any rights of
termination, amendment, acceleration or cancellation of, any material Contract to which the Company is a party or by which any
property or Assets of the Company are bound or affected. The businesses of the Company are not, to the Company’s knowledge,
being conducted, and shall not be conducted so long as Buyer owns any of the Common Shares or Warrants, in violation of any Law,
except as would not have or would not reasonably be expected to have a Material Adverse Effect. Except with respect to the SEC
and the principal Trading Market and as specifically contemplated by this Agreement or as would not have and would not reasonably
be expected to have a Material Adverse Effect, the Company is not required to obtain any Consent of, from, or with any Governmental
Authority, or any other Person, in order for it to execute, deliver or perform any of its Obligations under this Agreement or the
Transaction Documents in accordance with the terms hereof or thereof, or to issue and sell the Securities in accordance with the
terms hereof. All Consents which the Company is required to obtain pursuant to the immediately preceding sentence have been obtained
or effected on or prior to the date hereof or will be obtained or effected on or prior to Closing or as otherwise required under
the rules and regulations of the applicable Governmental Authority.

 

6.6            Issuance
of Securities. The Securities are duly authorized and, upon issuance in accordance with the terms hereof, (or, where applicable,
the Warrants), shall be duly issued, fully paid and non-assessable, and free, except as otherwise contemplated by this Agreement,
from all Encumbrances (other than restrictions imposed by federal and state securities Laws) with respect to the issue thereof,
and will be issued in compliance with all applicable United States federal and state securities Laws. Assuming the accuracy of
the representations and warranties of the Buyers set forth in Article V above, the offer and sale by the Company of the Securities
is exempt from: (i) the registration and prospectus delivery requirements of the Securities Act; and (ii) the registration and/or
qualification provisions of all applicable state and provincial securities and “blue sky” laws.

 

6.7            SEC
Documents; Financial Statements. The Common Stock is registered pursuant to Section 12 of the Exchange Act and the Company
has filed all reports, schedules, forms, statements and other documents required to be filed by it with the SEC under the Exchange
Act (all of the foregoing filed within the two (2) years preceding the date hereof or amended after the date hereof and all exhibits
included therein and financial statements and schedules thereto and documents incorporated by reference therein, being hereinafter
referred to as the “SEC Documents”). The Company is current with its filing obligations under the Exchange
Act. The Company represents and warrants that true and complete copies of the SEC Documents are available on the SEC’s website
(www.sec.gov) at no charge to Buyers, and Buyers acknowledge that each of them may retrieve all SEC Documents from such
website and each Buyer’s access to such SEC Documents through such website shall constitute delivery of the SEC Documents
to Buyers; provided, however, that if any Buyer is unable to obtain any of such SEC Documents from such website at
no charge, as result of such website not being available or any other reason beyond any Buyer’s control, then upon request
from such Buyer, the Company shall deliver to such Buyer true and complete copies of such SEC Documents. As of their respective
dates, the SEC Documents complied in all material respects with the requirements of the Exchange Act, and none of the SEC Documents,
at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated
under applicable Law (except as such statements have been amended or updated in subsequent filings prior the date hereof, which
amendments or updates are also part of the SEC Documents). As of their respective dates, the financial statements of the Company
included in the SEC Documents (“Financial Statements”) complied in all material respects with applicable
accounting requirements and the published rules and regulations of the SEC with respect thereto. All of the Financial Statements
have been prepared in accordance with GAAP, consistently applied, during the periods involved (except: (i) as may be otherwise
indicated in such Financial Statements or the notes thereto; or (ii) in the case of unaudited interim statements, to the extent
they may exclude footnotes or may be condensed or summary statements), and fairly present in all material respects the consolidated
financial position of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). To the knowledge of the
Company, no other information provided by or on behalf of the Company to the Buyers which is not included in the SEC Documents
contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements
therein, in the light of the circumstance under which they are or were made, not misleading.

 

    	12

    	 

    

 

6.8            Absence
of Certain Changes. Since the date the last of the SEC Documents was filed with the SEC there has been no event or circumstance
of any nature whatsoever that has resulted in, or would reasonably be expected to result in, a Material Adverse Effect.

 

6.9            Absence
of Litigation or Adverse Matters. Except as otherwise disclosed to the Buyers or as would not have or would not reasonably
be expected to have a Material Adverse Effect: (i) there is no Proceeding before or by any Governmental Authority or any other
Person, pending, or to the knowledge of the Company, threatened or contemplated by, against the Company, its business or Assets;
(ii) there are no outstanding Judgments against the Company, its business or Assets; and (iii) the Company is not in breach or
violation of any Contract.

 

6.10          Liabilities
and Indebtedness of the Company. The Company does not have any Obligations of any nature whatsoever, except Obligations (i)
set forth or adequately provided for in the Condensed Consolidated Balance Sheets or in the related Notes to the Condensed Consolidated
Financial Statements included in Company’s Quarterly Report on Form 10-Q for the period ended January 31, 2014 (the “Company
Balance Sheet”), (b) those incurred in the Ordinary Course of Business and not required to be set forth in the Company
Balance Sheet under GAAP, and (c) those incurred in the Ordinary Course of Business since the date of the Company Balance Sheet
and not reasonably likely to have a Material Adverse Effect.

 

6.11          Title
to Assets. The Company has good and marketable title to, or a valid leasehold interest in, all of its Assets which are material
to the business and operations of the Company as presently conducted, free and clear of all Encumbrances or restrictions on the
transfer or use of same. Except as would not have a Material Adverse Effect, the Company’s Assets are in good operating condition
and repair, ordinary wear and tear excepted.

 

6.12          Real
Estate.

 

(a)          Real
Property Ownership. The Company does not own any Real Property.

 

    	13

    	 

    

 

(b)          Real
Property Leases. Except for the Leases described in the SEC Documents (the “Company Leases”), the
Company does not lease any other Real Property required to be disclosed in the SEC Documents. With respect to each of the Company
Leases: (i) the Company has been in peaceful possession of the property leased thereunder and neither the Company nor the landlord
is in default thereunder; (ii) no waiver, indulgence or postponement of any of the Obligations thereunder has been granted by the
Company or landlord thereunder; and (iii) there exists no event, occurrence, condition or act known to the Company which, upon
notice or lapse of time or both, would be or could become a default thereunder or which could result in the termination of the
Company Leases, or any of them, and which would reasonably be expected to have a Material Adverse Effect. The Company has not received
any written notice to the effect that any of the Company Leases will not be renewed at the termination of the term of such Company
Leases.

 

6.13          Material
Contracts. Except for Material Contracts that have terminated or have been fully discharged pursuant to their terms as disclosed
in such Material Contracts as filed with the SEC, each of the Material Contracts is in full force and effect and is a valid and
binding Obligation of the parties thereto in accordance with the terms and conditions thereof. To the knowledge of the Company,
all Obligations required to be performed under the terms of each of the Material Contracts by any party thereto have been performed
by all parties thereto, and no party to any Material Contracts is in default with respect to any term or condition thereof, nor
has any event occurred which, through the passage of time or the giving of notice, or both, would constitute a default thereunder
or would cause the acceleration or modification of any Obligation of any party thereto or the creation of any Encumbrance upon
any of the Assets of the Company. Further, the Company has received no written notice, nor does the Company have any knowledge,
of any pending or contemplated termination of any of the Material Contracts.

 

6.14          Compliance
with Laws. To the knowledge of the Company, the Company is in material compliance with all Laws, except for instances of non-compliance
that, individually or in the aggregate, could not have a Material Adverse Effect. The Company has not received any written notice
that it is in violation of, has violated, or is under investigation with respect to, or has been threatened to be charged with,
any violation of any Law.

 

6.15          Intellectual
Property. The Company owns or possesses adequate and legally enforceable rights or licenses to use all trademarks, trade names,
service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and all other intellectual property rights necessary to conduct its business as now
conducted. The Company does not have any knowledge of any infringement by the Company of trademark, trade name rights, patents,
patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade secret or other
intellectual property rights of others, and, to the knowledge of the Company, there is no Claim being made or brought against,
or to the Company’s knowledge, being threatened against, the Company regarding trademark, trade name, patents, patent rights,
invention, copyright, license, service names, service marks, service mark registrations, trade secret or other intellectual property
infringement.

 

6.16          Labor
and Employment Matters. The Company is not involved in any labor dispute or, to the knowledge of the Company, is any such dispute
threatened. To the knowledge of the Company, none of the Company’s employees is a member of a union. To the knowledge of
the Company, the Company has complied in all material respects with all Laws relating to employment matters, civil rights and equal
employment opportunities.

 

6.17          Employee
Benefit Plans. Schedule 6.17 sets forth all employee benefit plans maintained, established or sponsored by the Company,
or in or to which the Company participates or contributes, which is subject to the Employee Retirement Income Security Act of 1974,
as amended (“ERISA”). The Company has made all required contributions and has no liability to any such
employee benefit plan, other than liability for health plan continuation coverage described in Part 6 of Title I(B) of ERISA, and
has materially complied with all applicable laws for any such employee benefit plan.

 

    	14

    	 

    

 

6.18          Tax
Matters. The Company has made and timely filed all United States federal Tax Returns and all other material Tax Returns required
by any jurisdiction to which it is subject, and each such Tax Return has been prepared in material compliance with all applicable
Laws, and all such Tax Returns are true and accurate in all material respects. Except and only to the extent that the Company has
set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported Taxes, the Company has timely
paid all Taxes shown or determined to be due on such Tax Returns, except those being contested in good faith, and the Company has
set aside on its books provision reasonably adequate for the payment of all Taxes for periods subsequent to the periods to which
such Tax Returns apply. There are no unpaid Taxes in any material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company know of no basis for any such claim. The Company has withheld and paid all Taxes to the appropriate
Governmental Authority required to have been withheld and paid in connection with amounts paid or owing to any Person. There is
no Proceeding or Claim for refund now in progress, pending or, to the Company’s knowledge, threatened against or with respect
to the Company regarding Taxes.

 

6.19          Insurance.
The Company is covered by valid, outstanding and enforceable policies of insurance which were issued to it by reputable insurers
of recognized financial responsibility, covering its properties, Assets and businesses against losses and risks normally insured
against by other corporations or entities in the same or similar lines of businesses as the Company is engaged and in coverage
amounts which are typically and reasonably carried by such other corporations or entities (the “Insurance Policies”).
Such Insurance Policies are in full force and effect, and all premiums due thereon have been paid. None of the Insurance Policies
will lapse or terminate as a result of the transactions contemplated by this Agreement. The Company has complied in all material
respects with the provisions of such Insurance Policies. The Company has not received notice, written or oral, that any of its
existing insurance coverage has been or will be refused or that its existing Insurance Policies will not be renewed.

 

6.20          Permits.
To the extent that failure to possess a Permit would reasonably result in a Material Adverse Effect, the Company possesses all
material Permits necessary to conduct its business, and the Company has not received any notice of, or is otherwise involved in
any Proceedings relating to, the revocation or modification of any such Permits. All such Permits are valid and in full force and
effect and the Company is in material compliance with the respective requirements of all such Permits.

 

6.21          Environmental
Laws. To the extent that non-compliance would reasonably result in a Material Adverse Effect, the Company is and has at all
times been in compliance with any and all applicable material Environmental Requirements, and there are no pending Claims against
the Company relating to any material Environmental Requirements.

 

6.22          Illegal
Payments. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has,
in the course of his actions for, or on behalf of, the Company: (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of
the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.

 

    	15

    	 

    

 

6.23          Related
Party Transactions. Except as disclosed in the SEC Documents or as contemplated by this Agreement except for arm’s length
transactions pursuant to which the Company makes payments in the Ordinary Course of Business upon terms no less favorable than
the Company could obtain from third parties, none of the officers, directors or employees of the Company, nor any stockholders
who own, legally or beneficially, five percent (5%) or more of the issued and outstanding shares of any class of the Company’s
capital stock (each a “Material Shareholder”), is presently a party to any transaction with the Company
(other than for services as employees, officers and directors), including any Contract providing for the furnishing of services
to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from, any officer,
director or such employee or Material Shareholder or, to the best knowledge of the Company, any other Person in which any officer,
director, or any such employee or Material Shareholder has a substantial or material interest in or of which any officer, director
or employee of the Company or Material Shareholder is an officer, director, trustee or partner. There are no Claims that have been
made in writing or material disputes of any nature or kind between the Company and any officer, director or employee of the Company
or any Material Shareholder, or between any of them, relating to the Company and its business.

 

6.24          Internal
Accounting Controls. Except as set forth in the SEC Documents, the Company and each of its Subsidiaries maintain a system of
internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to Assets is permitted
only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for Assets
is compared with the existing Assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

6.25          Acknowledgment
Regarding Buyers’ Purchase of the Securities. The Company acknowledges and agrees that each Buyer is acting solely in
the capacity of an arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company
further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to this Agreement and the transactions contemplated hereby and any advice given by any Buyer or any of its representatives
or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to such Buyer’s
purchase of the Securities. The Company further represents to each Buyer that the Company’s decision to enter into this Agreement
has been based solely on the independent evaluation by the Company and its representatives.

 

6.26          Listing
and Maintenance Requirements. The Company’s Common Stock is registered pursuant to Section 12(b) of the Exchange Act,
and the Company has taken no action designed to, or which to the best of its knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the SEC is contemplating
terminating such registration.

 

6.27          Advisory
Fees. Roth Capital Partners, LLC (the “Financial Advisor”) is acting as a financial advisor on behalf
of the Company in connection with the transactions contemplated hereby. The Company shall be responsible for the payment of any
financial advisory fees owing to the Financial Advisor relating to or arising out of the transactions contemplated hereby. Except
for the Financial Advisor, there is no Person acting on behalf of the Company who is entitled to or has any claim for any financial
advisory, brokerage or finder’s fee or commission in connection with the execution of this Agreement or the consummation
of the transactions contemplated hereby.

 

6.28          Full
Disclosure. All the representations and warranties made by the Company herein or in the Schedules hereto, and all of the other
written information pertaining to the transaction contemplated herein made or given by the Company or included in the SEC Documents,
do not omit any material information required to make the statements and information provided, in light of the circumstances under
which they were made or provided, not misleading.

 

    	16

    	 

    

 

6.29         No
Disqualification Events. None of the Company, any of the Company’s predecessors, any affiliated issuer of the Company,
any director of the Company, executive officer of the Company (as that term is defined in Securities Act Rule 501(f)), other officer
of the Company participating in the transactions contemplated hereby, any beneficial owner of 20% or more of the Company’s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Securities
Act Rule 405) connected with the Company in any capacity at the time of sale of the Securities (each, an “Issuer Covered
Person” and, together, “Issuer Covered Persons”) is subject to any Disqualification Event,
except for a Disqualification Event covered by Securities Act Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care
to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent
applicable, with its disclosure obligations under Securities Act Rule 506(e).

 

6.30          No
Other Representations. Each Buyer acknowledges and agrees that the Company make no representations or warranties whatsoever,
express or implied, except for those specifically set forth in this Article VI.

 

ARTICLE
VII

COVENANTS

 

7.1            Form
D. If required by applicable Law, the Company agrees to file a Form D with respect to the Securities as required under Regulation
D of the Securities Act and to provide a copy thereof to each Buyer promptly after such filing. The Company shall, on or before
the Closing Date, take such action as the Company shall reasonably determine is necessary to qualify the Securities, or obtain
an exemption for the Securities for sale to each of the Buyers at Closing pursuant to this Agreement under applicable securities
or “Blue Sky” Laws of the states of the United States, and shall provide evidence of any such action so taken to the
Buyers on or prior to the Closing Date.

 

7.2            Use
of Proceeds. The proceeds from the purchase and sale of the Units shall be used by the Company for general working capital
purposes.

 

7.3            Affirmative
Covenants. So long as the Buyers collectively own, legally or beneficially, at least twenty percent (20%) of the Common Shares,
unless otherwise consented to in writing by the Company and a Majority of the Buyers, the Company hereby covenants as follows:

 

(a)          Corporate
Existence. At all times preserve and maintain its: (i) existence and good standing in the jurisdiction of its organization;
and (ii) its qualification to do business and good standing in each jurisdiction where the nature of its business makes such qualification
necessary, and shall at all times continue as a going concern.

 

(b)          Tax
Liabilities. At all times pay and discharge all material Taxes upon, and all Claims (including claims for labor, materials
and supplies) against the Company and each of its Subsidiaries or any of its or their properties or Assets, before the same shall
become delinquent and before penalties accrue thereon, unless and to the extent that the same are being contested in good faith
by appropriate proceedings and for which adequate reserves in accordance with GAAP are being maintained.

 

(c)          Maintain
Property. At all times maintain, preserve and keep all of its material Assets in good repair, working order and condition,
normal wear and tear excepted, and shall from time to time, as the Company deems appropriate in its reasonable judgment, make all
needful and proper repairs, renewals, replacements, and additions thereto so that at all times the efficiency thereof shall be
fully preserved and maintained.

 

    	17

    	 

    

 

(d)          Reporting
Status; Listing. (i) File in a timely manner all reports required to be filed under the Securities Act, the Exchange Act or
any securities Laws and regulations thereof applicable to the Company of any state of the United States, or by the rules and regulations
of the principal Trading Market; (ii) not terminate its status as an issuer required to file reports under the Exchange Act even
if the Exchange Act or the rules and regulations thereunder would otherwise permit such termination; (iii) if required by the rules
and regulations of the principal Trading Market, promptly secure the listing of any of the Securities consisting of Common Stock
upon the principal Trading Market (subject to official notice of issuance) and, take all commercially reasonable action under its
control to maintain the continued listing, quotation and trading of its Common Stock on one or more Trading Markets, and the Company
shall comply in all respects with the Company’s reporting, filing and other Obligations under the bylaws or rules of the
principal Trading Market, the Financial Industry Regulatory Authority, Inc. and such other Governmental Authorities, as applicable.

 

(e)          Rule
144. With a view to making available to each Buyer the benefits of Rule 144 under the Securities Act (“Rule 144”),
or any similar rule or regulation of the SEC that may at any time permit Buyers to sell any of the Securities to the public without
registration, the Company represents and warrants that: (i) the Company is, and has been for a period of at least ninety (90) days
immediately preceding the date hereof, subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; (ii) the
Company has filed all required reports under Section 13 or 15(d) of the Exchange Act, as applicable, during the twelve (12) months
preceding the Closing Date (or for such shorter period that the Company was required to file such reports); (iii) the Company is
not an issuer defined as a “Shell Company” (as hereinafter defined); and (iv) if the Company has, at any time, been
an issuer defined as a Shell Company, the Company has: (A) not been an issuer defined as a Shell Company for at least six (6) months
prior to the Closing Date; and (B) has satisfied the requirements of Rule 144(i) (including, without limitation, the proper filing
of “Form 10 information” at least six (6) months prior to the Closing Date). For the purposes hereof, the term “Shell
Company” shall mean an issuer that meets the description of a shell company as defined under Rule 144. In addition,
so long as any Buyer owns, legally or beneficially, any of the Securities, the Company shall, at its sole expense:

 

(A)         Use
commercially reasonable efforts to make, keep and ensure that adequate current public information with respect to the Company,
as required in accordance with Rule 144, is publicly available;

 

(B)         furnish
to each Buyer, promptly upon reasonable request, such information as may be reasonably requested by each Buyer to permit each Buyer
to sell any of the Securities pursuant to Rule 144 without limitation or restriction; and

 

(C)         promptly
at the request of each Buyer, give the Company’s transfer agent instructions to the effect that, upon the transfer agent’s
receipt from any Buyer of a certificate (a “Rule 144 Certificate”) certifying the eligibility for sale
under Rule 144 of any portion of the Securities which such Buyer proposes to sell (the “Securities Being Sold”),
and receipt by the transfer agent of a “Rule 144 Opinion” from the Company or its counsel (or from such Buyer and its
counsel as permitted below), the transfer agent is to effect the transfer of the Securities Being Sold and issue to such transferee(s)
thereof one or more stock certificates representing the transferred Securities Being Sold without any restrictive legend and without
recording any restrictions on the transferability of such shares on the transfer agent’s books and records. If the transfer
agent requires any additional documentation in connection with any proposed transfer by any Buyer of any Securities Being Sold,
the Company shall promptly deliver or cause to be delivered to the transfer agent or to any other Person, all such additional documentation
as may be necessary to effectuate the transfer of the Securities Being Sold and the issuance of an unlegended certificate to any
transferee thereof, all at the Company’s expense.

 

    	18

    	 

    

 

7.4            Fees
and Expenses. Except as set forth in the Transaction Documents, each party shall bear its own expenses in connection with the
transactions contemplated by this Agreement and the Transaction Documents; provided, however, that the Company shall
pay the financial advisory fees owing to the Financial Advisor relating to or arising out of the transactions contemplated hereby.

 

7.5            Reservation
of Shares. The Company shall take all action reasonably necessary to at all times have authorized, and reserved for the purpose
of issuance, such number of shares of Common Stock as shall be necessary for the issuance of the shares of Common Stock and for
the issuance of the Warrant Shares upon exercise of the Warrants (collectively, the “Share Reserve”).
If at any time the Share Reserve is insufficient, the Company shall take all required measures to implement an increase of the
Share Reserve accordingly. If the Company does not have sufficient authorized and unissued shares of Common Stock available to
increase the Share Reserve, the Company shall call and hold a special meeting of the stockholders of the Company within sixty (60)
business days of such occurrence, for the sole purpose of increasing the number of shares of Common Stock authorized. The Company’s
management shall recommend to the stockholders to vote in favor of increasing the number of shares of Common Stock authorized.

 

7.6            Certain
Transactions; Confidentiality. Each Buyer, severally and not jointly with the other Buyers, covenants that neither it, nor
any Affiliate acting on its behalf or pursuant to any understanding with it, will execute any purchases or sales, including Short
Sales, of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced as described in Section 7.7. Each Buyer,
severally and not jointly with the other Buyers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company, such Buyer will maintain the confidentiality of the existence and terms of this transaction
and the information included in the Transaction Documents. Notwithstanding the foregoing, in the case of a Buyer that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Buyer’s assets and the portfolio
managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Buyer’s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement.

 

7.7            Disclosure
of Transactions and Other Material Information. On or before 5:30 p.m., New York time, on the fourth (4th) business
day after the date of this Agreement, the Company shall file a Current Report on Form 8-K describing all the material terms of
the transactions contemplated by the Transaction Documents in the form required by the Exchange Act (the “8-K Filing”).
As of the filing of the 8-K Filing, to the knowledge of the Company, the Company shall have publicly disclosed all material, non-public
information (if any) provided to any of the Buyers by the Company or any of its Subsidiaries or any of their respective officers,
directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. Neither the Company,
its Subsidiaries nor any Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated
hereby; provided, however, the Company shall be entitled, without the prior approval of any Buyer, to make any press
release or other public disclosure with respect to such transactions (i) in substantial conformity with the 8-K Filing and (ii)
as is required by applicable Law and regulations. Notwithstanding the foregoing, the Company shall not publicly disclose the name
of any Buyer, or include the name of any Buyer in any filing with the SEC or any regulatory agency or Trading Market, without the
prior written consent of such Buyer, except: (a) as required by federal securities Law in connection with (i) the 8-K Filing, (ii)
any registration statement contemplated by the Registration Rights Agreement and (iii) the filing of final Transaction Documents
with the SEC and (b) to the extent such disclosure is required by Law or Trading Market regulations, in which case the Company
shall provide the Buyers with prior notice of such disclosure permitted under this clause (b).

 

    	19

    	 

    

 

ARTICLE
VIII

CONDITIONS
PRECEDENT TO THE COMPANY’S OBLIGATIONS TO SELL

 

The obligation of the
Company hereunder to issue and sell the Securities to the Buyers at the Closing is subject to the satisfaction, at or before the
Closing Date, of each of the following conditions, provided that these conditions are for the Company’s sole benefit and
may be waived by the Company at any time in its sole discretion:

 

8.1            Each
of the Buyers shall have executed the Transaction Documents that require Buyers’ execution, and delivered them to the Company.

 

8.2            Each
of the Buyers shall have paid the portion of the Purchase Price applicable to such Buyer to the Company.

 

8.3            The
representations and warranties of the Buyers shall be true and correct as of the date when made and as of the Closing Date as though
made at that time (except for representations and warranties that speak as of a specific date), except where the failure of such
representations to be so true and correct (without giving effect to any qualifiers as to materiality in Article V above)
would not materially and adversely affect (i) the Buyers’ ability to consummate the Transactions contemplated hereby or (ii)
the availability of an exemption from the registration requirements of the Securities Act for the sale of Securities contemplated
hereby.

 

8.4            The
Buyers shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Buyers at or prior to the Closing Date.

 

ARTICLE
IX

CONDITIONS
PRECEDENT TO THE BUYERS’ OBLIGATIONS TO PURCHASE

 

The obligation of the
Buyers hereunder to purchase the Units at the Closing is subject to the satisfaction, at or before the Closing Date, of each of
the following conditions (which conditions shall be deemed satisfied upon the occurrence of the Closing), provided that these conditions
are for the Buyers’ sole benefit and may be waived by the Buyers at any time in their sole discretion:

 

9.1            The
Company shall have executed and delivered the Transaction Documents and delivered the same to the Buyers.

 

9.2            The
representations and warranties of the Company shall be true and as of the date when made and as of the Closing Date as though made
at that time (except for representations and warranties that speak as of a specific date, in which case they shall be true and
correct in all material respects as of such specified date), except where the failure of such representations to be so true and
correct (without giving effect to any qualifiers as to materiality in Article VI above) would not have a Material Adverse
Effect.

 

9.3            The
Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date.

 

9.4            The
Buyers shall have received an opinion of counsel from counsel to the Company in a form satisfactory to the Buyers and their counsel.

 

    	20

    	 

    

 

9.5           The
Company shall have each executed and delivered to Buyers a closing certificate in substance and form required by Buyers, which
closing certificate shall include and attach as exhibits: (i) a true copy of a certificate of good standing evidencing the formation
and good standing of the Company and each of its Subsidiaries (other than for Crossroads Europe), as applicable, from the secretary
of state (or comparable office) from the jurisdiction in which they are each incorporated, as of a date within ten (10) days of
the Closing Date; (ii) the Company’s and each of the Subsidiaries’ (other than for Crossroads Europe) Certificate of
Incorporation or similar instrument; (iii) the Company’s and each of the Subsidiaries’ Bylaws or similar document;
and (iv) copies of the resolutions of the board of directors of the Company or a duly authorized committee thereof (the “Committee”),
consistent with Section 6.3, as adopted by the Company’s board of directors or Committee in a form reasonably acceptable
to Buyers; and the Company shall have executed and delivered to Buyers a certificate of the secretary of the Company as to the
good standing of Crossroads Europe.

 

9.6           No
event shall have occurred between the execution of this Agreement and the Closing that has had or would reasonably be expected
to have a Material Adverse Effect.

 

ARTICLE
X

INDEMNIFICATION

 

10.1          Company’s
Obligation to Indemnify. In consideration of the Buyers’ execution and delivery of this Agreement and acquiring the Securities
hereunder, and in addition to all of the Company’s other obligations under this Agreement, the Company hereby agrees to defend
and indemnify each Buyer and each Buyer’s Affiliates and subsidiaries, and their respective directors, officers, employees,
agents and representatives, and the successors and assigns of each of them (collectively, the “Buyer Indemnified Parties”)
and the Company does hereby agree to hold the Buyer Indemnified Parties harmless, from and against any and all Claims made, brought
or asserted against the Buyer Indemnified Parties, or any one of them, and the Company hereby agrees to pay or reimburse the Buyer
Indemnified Parties for any and all Claims payable by any of the Buyer Indemnified Parties to any Person, including reasonable
attorneys’ and paralegals’ fees and expenses, court costs, settlement amounts, costs of investigation, through all
negotiations, mediations, arbitrations, trial and appellate levels, as a result of, or arising out of, or relating to: (i) any
misrepresentation or breach of any representation or warranty made by the Company in this Agreement, the Transaction Documents
or any other certificate, instrument or document contemplated hereby or thereby; (ii) any breach of any covenant, agreement or
Obligation of the Company contained in this Agreement, the Transaction Documents or any other certificate, instrument or document
contemplated hereby or thereby; or (iii) any Claims brought or made against the Buyer Indemnified Parties, or any one of them,
by any Person and arising out of or resulting from the execution, delivery, performance or enforcement of this Agreement, the Transaction
Documents or any other instrument, document or agreement executed pursuant hereto or thereto, or the status of the Buyers of any
of the Securities, as a buyer and holder of such Securities in the Company. To the extent that the foregoing undertaking by the
Company may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of
each of the Claims covered hereby, which is permissible under applicable Law. If any action shall be brought against any Buyer
in respect of which indemnity may be sought pursuant to this Agreement, such Buyer shall promptly notify the Company in writing,
and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to such
Buyer. Any Buyer shall have the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Buyer except to the extent that (i) the employment thereof
has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume
such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate counsel, a material
conflict on any material issue between the position of the Company and the position of such Buyer, in which case the Company shall
be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to
any Buyer under this indemnity: (y) for any settlement by a Buyer in connection with any Claim effected without the Company’s
prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed; or (z) to the extent, but only
to the extent, that a Claim is attributable to any Buyer’s breach of any of the representations, warranties, covenants or
agreements made by such Buyer in this Agreement, the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby.

 

    	21

    	 

    

 

ARTICLE
XI

MATTERS
RELATING TO THE BUYERS

 

11.1          Independent
Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under this Agreement and the Transaction Documents
are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance
of the obligations of any other Buyer under any one or more of the Transaction Documents. The decision of each Buyer to purchase
the Securities pursuant to the Transaction Documents has been made by each such Buyer independently of any other Buyer and independently
of any information, materials, statements or opinions as to the business, affairs, operations, Assets, properties, liabilities,
results of operations, condition (financial or otherwise) or prospects of the Company or of its Subsidiaries, if any, which may
have been made or given by any other Buyer or any of their respective officers, directors, principals, employees, agents, counsel
or representatives (collectively, including the Buyer in question, the “Buyer Representatives”). No Buyer
Representative shall have any liability to any other Buyer or the Company relating to or arising from any such information, materials,
statements or opinions, if any. Each Buyer acknowledges that no other Buyer has acted as agent for such Buyer in connection with
making its investment hereunder and that no Buyer will be acting as agent of such other Buyer in connection with monitoring its
investment in the Securities or enforcing its rights under the Transaction Documents. Each Buyer shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Buyer to be joined as an additional party in any Proceeding for such purpose.
The Company and each of the Buyers acknowledge that, for reasons of administrative convenience: (i) the Transaction Documents have
been prepared and/or negotiated by counsel for one of the Buyers, and that such counsel does not represent all of the Buyers with
respect to the transactions contemplated hereby, and each other Buyer has retained its own counsel (or had the opportunity to do
so) with respect to such transactions; and (ii) the Company has elected to provide each of the Buyers with the same Transaction
Documents for the purpose of closing a transaction with multiple Buyers and not because it was required or requested to do so by
any Buyer. In furtherance of the foregoing, and not in limitation thereof, the Company and the Buyers acknowledge that nothing
contained in this Agreement or in any Transaction Document, and no action taken by any Buyer pursuant thereto, shall be deemed
to constitute any two or more Buyers as a partnership, an association, a joint venture or any other kind of entity, or create a
presumption that the Buyers are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents.

 

11.2          Equal
Treatment of Buyers. No consideration shall be offered or paid to any Buyer to amend or consent to a waiver or modification
of any provision of any of the Transaction Documents, unless the same consideration is also offered to all of the other Buyers
parties to the Transaction Documents.

 

    	22

    	 

    

 

ARTICLE
XII

MISCELLANEOUS

 

12.1          Notices.
All notices of request, demand and other communications hereunder shall be addressed to the parties as follows:

 

	If to the Company:	Crossroads Systems, Inc.
	 	11000 North Mopac Expressway
	 	Austin, TX 78759
	 	Facsimile: (512) 349-0304
	 	Attn: Chief Executive Officer
	 	 
	With a copy to:	Andrews Kurth LLP
	 	111 Congress Ave Suite 1700
	 	Austin, TX 78701
	 	Facsimile: (512) 320-9292
	 	Attn: J. Matthew Lyons
	 	 
	If to the Buyers:	To each Buyer based on the information
	 	Set forth in the Schedule A attached hereto

 

unless the address is changed by the party
by like notice given to the other parties. Notice shall be in writing and shall be deemed delivered: (i) if mailed by certified
mail, return receipt requested, postage prepaid and properly addressed to the address above, then three (3) business days after
deposit of same in a regularly maintained U.S. Mail receptacle; or (ii) if mailed by Federal Express, UPS or other nationally recognized
overnight courier service, next business morning delivery, then one (1) business day after deposit of same in a regularly maintained
receptacle of such overnight courier; or (iii) if hand delivered, then upon hand delivery thereof to the address indicated on or
prior to 5:00 p.m., EST, on a business day. Any notice hand delivered after 5:00 p.m., EST, shall be deemed delivered on the following
business day. Notwithstanding the foregoing, notices, consents, waivers or other communications referred to in this Agreement may
be sent by facsimile, e-mail, or other method of delivery, but shall be deemed to have been delivered only when the sending party
has confirmed (by reply e-mail or some other form of written confirmation from the receiving party) that the notice has been received
by the other party.

 

12.2          Entire
Agreement. This Agreement, including the Exhibits and Schedules attached hereto and the documents delivered pursuant hereto,
including the Transaction Documents, set forth all the promises, covenants, agreements, conditions and understandings between the
parties hereto with respect to the subject matter hereof and thereof, and supersede all prior and contemporaneous agreements, understandings,
inducements or conditions, expressed or implied, oral or written.

 

12.3          Assignment.

 

(a)          The
Company may not sell or assign this Agreement or any of the Transaction Documents, or any portion thereof, either voluntarily or
by operation of law, nor delegate any of its duties of obligations hereunder or thereunder, without the prior written consent of
the Buyers, which consent may be withheld in Buyers’ sole and absolute discretion.

 

(b)          Each
Buyer may transfer or assign, in whole or from time to time in part, to one or more Persons its rights in this Agreement or any
of the other Transaction Documents in connection with the transfer of the Securities by such Buyer to such Person, provided that
such Buyer complies with all Laws applicable thereto and provides written notice of assignment to the Company promptly after such
assignment is effected and such assignee agrees in writing to be bound by the terms of the Transaction Documents and can and does
satisfy each of the representations and warranties of the transferring Buyer.

 

    	23

    	 

    

 

12.4          Binding
Effect. This Agreement shall be binding upon the parties hereto, their respective successors and permitted assigns.

 

12.5          Amendment.
The parties hereby irrevocably agree that no attempted amendment, modification, or change of this Agreement shall be valid and
effective, unless the Company and a Majority of the Buyers unanimously agree in writing to such amendment, modification or change.

 

12.6          No
Waiver. No waiver of any provision of this Agreement shall be effective, unless it is in writing and signed by the party against
whom it is asserted, and any such written waiver shall only be applicable to the specific instance to which it relates and shall
not be deemed to be a continuing or future waiver.

 

12.7          Gender
and Use of Singular and Plural. All pronouns shall be deemed to refer to the masculine, feminine, neuter, singular or plural,
as the identity of the party or parties or their personal representatives, successors and assigns may require.

 

12.8          Execution.
This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and considered one and
the same Agreement, and same shall become effective when counterparts have been signed by each party and each party has delivered
its signed counterpart to the other party. In the event that any signature is delivered by facsimile transmission or by e-mail
delivery of a “.pdf” format file or other similar format file, such signature shall be deemed an original for all purposes
and shall create a valid and binding obligation of the party executing same with the same force and effect as if such facsimile
or “.pdf” signature page was an original thereof.

 

12.9          Headings.
The article and section headings contained in this Agreement are inserted for convenience only and shall not affect in any way
the meaning or interpretation of the Agreement.

 

12.10        Governing
Law; Venue. This Agreement shall be construed in accordance with the laws of the State of Delaware, without regard to the principles
of conflicts of laws. The parties further agree that any action between them shall be heard in City of Wilmington, Delaware and
expressly consent to the jurisdiction and venue of the state and federal courts sitting in City of Wilmington, Delaware for the
adjudication of any civil action asserted pursuant to this Agreement.

 

12.11        Further
Assurances. The parties hereto will execute and deliver such further instruments and do such further acts and things as may
be reasonably required to carry out the intent and purposes of this Agreement.

 

12.12        Survival.
The covenants, agreements, representations and warranties made by the Company and the Buyers herein shall survive for the duration
of their respective statute of limitations. Each Buyer shall be responsible only for its own
covenants, agreements, representations and warranties hereunder.

 

12.13        Time
is of the Essence. The parties hereby agree that time is of the essence with respect to performance of each of the parties’
Obligations under this Agreement. The parties agree that in the event that any date on which performance is to occur falls on a
Saturday, Sunday or state or national holiday, then the time for such performance shall be extended until the next business day
thereafter occurring.

 

    	24

    	 

    

 

12.14        Joint
Preparation. The preparation of this Agreement has been a joint effort of the parties and the resulting documents shall not,
solely as a matter of judicial construction, be construed more severely against one of the parties than the other.

 

12.15        Severability.
If any one of the provisions contained in this Agreement, for any reason, shall be held invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement, and this Agreement
shall remain in full force and effect and be construed as if the invalid, illegal or unenforceable provision had never been contained
herein.

 

12.16        No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

12.17        WAIVER
OF JURY TRIAL. THE BUYERS AND THE COMPANY, AFTER CONSULTING OR HAVING HAD THE OPPORTUNITY TO CONSULT WITH COUNSEL, EACH KNOWINGLY,
VOLUNTARILY AND INTENTIONALLY WAIVES, IRREVOCABLY, THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING BASED HEREON,
OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENT OR ANY OTHER AGREEMENT EXECUTED
OR CONTEMPLATED TO BE EXECUTED IN CONJUNCTION WITH THIS AGREEMENT, OR ANY COURSE OF CONDUCT OR COURSE OF DEALING IN WHICH THE BUYERS
AND THE COMPANY ARE ADVERSE PARTIES. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE BUYERS TO PURCHASE THE UNITS.

 

12.18        Compliance
with Federal Law. The Company shall: (i) use its best efforts to ensure that no Person who owns a controlling interest in or
otherwise controls the Company is or shall at any time be listed on the Specially Designated Nationals and Blocked Person List
or other similar lists maintained by the Office of Foreign Assets Control (“OFAC”), the Department of
the Treasury, included in any Executive Orders or in any other similar lists of any Governmental Authority; and (ii) not use or
permit the use of the proceeds of the purchase of the Securities to violate any of the foreign asset control regulations of OFAC
or any enabling statute, Executive Order relating thereto or any other requirements or restrictions imposed by any Governmental
Authority.

 

12.19        Waiver
of Conflicts. Each party to this Agreement acknowledges that legal counsel for the Company, Andrews Kurth LLP (“AK”),
may in the future perform legal services for one or more of the Buyers or their respective affiliates in matters unrelated to the
transactions contemplated by this Agreement. Each party to this Agreement hereby (a) acknowledges that it has had an opportunity
to ask for and has obtained information relevant to such representation, including disclosure of the reasonably foreseeable adverse
consequences of such representation; and (b) acknowledges that with respect to the transactions contemplated herein, AK has represented
the Company and not any Buyer. The Company and Buyer each hereby confirm that AK may act as the Company’s counsel in connection
with the transactions contemplated by the Transaction Documents.

 

[SIGNATURES ON THE FOLLOWING
PAGE]

 

    	25

    	 

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be executed as of the date and year set forth above.

 

	 	COMPANY:
	 	 
	 	CROSSROADS SYSTEMS, INC.,
	 	a Delaware corporation
	 	 
	 	By:	/s/ Richard K. Coleman, Jr.
	 	 	 Richard K. Coleman, Jr.
	 	 	 Chief Executive Officer

  

	 	BUYERS:
	 	 
	 	See signature page for each Buyer attached hereto

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]